Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment

AI Summary

Researchers from Hokkaido University and collaborators report a mechanism that helps metastatic colorectal cancer evade the immune system. The findings challenge a longstanding theory and may point to new treatment approaches.

Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC). Their findings challenge a 30-year-old theory about cancer.